Engineers Gate Manager’s Immunocore IMCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.92M Buy
60,327
+46,435
+334% +$1.37M 0.02% 712
2026
Q1
$419K Buy
+13,892
New +$449K 0.01% 1505
2025
Q4
Sell
-20,864
Closed -$758K 2301
2025
Q3
$758K Buy
20,864
+6,104
+41% +$207K 0.01% 1301
2025
Q2
$463K Buy
+14,760
New +$459K 0.01% 1514
2024
Q4
Sell
-24,304
Closed -$757K 2396
2024
Q3
$757K Sell
24,304
-13,875
-36% -$505K 0.01% 1167
2024
Q2
$1.29M Buy
+38,179
New +$1.95M 0.03% 766

Other funds holding IMCR

Engineers Gate Manager's IMCR Position: Q2 2026 in Review

Engineers Gate Manager increased its Immunocore (IMCR) stake by 334% in Q2 2026, buying an estimated $1.37M and bringing the position to 60,327 shares worth $1.92M. The position accounts for 0.02% of the portfolio, ranked #712.

Engineers Gate Manager first reported a position in IMCR in Q2 2024 and has held it in 6 quarters since. 136 funds tracked by Wall St. Rank hold IMCR as of Q2 2026.

  • Engineers Gate Manager held 60,327 shares of Immunocore worth $1.92M as of Q2 2026.
  • Engineers Gate Manager bought 46,435 Immunocore shares in Q2 2026, an estimated $1.37M.
  • Immunocore made up 0.02% of Engineers Gate Manager's portfolio in Q2 2026, its #712 holding.
  • Engineers Gate Manager first reported a position in Immunocore in Q2 2024 and has held it in 6 quarters since.
  • 136 funds tracked by Wall St. Rank held Immunocore as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.